BB Biotech

BB Biotech as of June 30, 2012

Portfolio Holdings for BB Biotech

BB Biotech holds 20 positions in its portfolio as reported in the June 2012 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Celgene Corporation 16.3 $175M 2.7M 64.16
Vertex Pharmaceuticals Incorporated (VRTX) 12.1 $130M 2.3M 55.92
Gilead Sciences (GILD) 10.1 $108M 2.1M 51.28
Incyte Corporation (INCY) 8.8 $95M 4.2M 22.70
ISIS Pharmaceuticals 8.2 $88M 7.4M 12.00
ImmunoGen (IMGN) 5.7 $61M 3.7M 16.74
Amylin Pharmaceuticals 5.7 $61M 2.2M 28.20
Ariad Pharmaceuticals 5.0 $53M 3.1M 17.21
Halozyme Therapeutics (HALO) 4.2 $45M 5.1M 8.86
Alexion Pharmaceuticals 4.2 $45M 450k 99.30
BioMarin Pharmaceutical (BMRN) 3.6 $39M 976k 39.58
Medicines Company 3.4 $36M 1.6M 22.94
Human Genome Sciences 2.5 $26M 2.0M 13.13
Onyx Pharmaceuticals 2.2 $24M 357k 66.45
Optimer Pharmaceuticals 2.1 $23M 1.5M 15.46
Theravance 1.8 $19M 843k 22.22
Idenix Pharmaceuticals 1.2 $13M 1.3M 10.28
Dendreon Corporation 1.1 $11M 1.5M 7.40
Endocyte 1.0 $11M 1.3M 8.22
Achillion Pharmaceuticals 0.9 $9.8M 1.6M 6.20